NCPA Annual Convention & Expo

AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.

AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.

Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.

Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.

Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Pharmacy professionals gather to discuss innovative solutions, fostering collaboration and community engagement at the National Community Pharmacists Association 2025 Convention & Expo.

Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.

Lisa Schwartz, PharmD, discusses community pharmacies’ displeasure with provisions backing the Medicare Drug Price Negotiation Program.

Lisa Schwartz, PharmD, discusses the importance of the Medicare Transaction Facilitator as community pharmacies head into a new year of the Medicare Drug Price Negotiation Program.

The final part of our interview with Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, focuses on the relationships between state- and federal-level PBM reform.

In part 4 of our interview with Jennifer Griffin, PharmD, MS, she discusses different payer engagement models and the pharmacists’ ability to understand and improve medical billing tactics.

At the NCPA 2025 Annual Convention & Expo, Lucas Morgan, Esq, shareholder with Buchanan Ingersoll & Rooney, joined us to discuss ongoing PBM legislation in the state of Arkansas.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of pharmacy businesses to understand evolving and emerging health care technology.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses revenue cycle management and how it has developed within community pharmacy.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses how behavioral health services in community pharmacy help patients receive care impacting all factors of their health and not just medications.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, shareholders with Buchanan Ingersoll & Rooney, discuss Utah’s pharmacy benefit manager pass-through rebate law.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses the importance of automation and its emerging role in pharmacy practices.

Before delinking, pharmacy benefit managers were able to tie their fees to significantly high-priced medications, in turn receiving large percentages of compensation rather than flat, fixed fees.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses the basis of having reimbursement pathways in community pharmacy that consistently generate revenue.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses the growing opportunities for pharmacies to support patients’ behavioral health management.

Tara Pfund, PharmD, chief strategy officer with Cascadia Pharmacy Group, discusses her experience developing new technology workflows that drive pharmacy efficiency.

Jennifer Griffin, PharmD, MS, clinical pharmacist at Harps Food Stores, Inc, discusses billing for clinical services and how pharmacies need to prioritize credentialing.

Andrew M. Peterson, PharmD, PhD, FCPP, discusses social determinants of health, their impact on patients, and why pharmacists struggle to address them.

Emlah Tubuo, PharmD, MS, owner of Powell Pharmacy and founder of Emlah Consulting LLC, discusses the overall importance of supplement sales in community pharmacies.

Amaal J. Starling, MD, FAAN, FAHS, and Courtney Hahs, PharmD, discuss the excitement surrounding emerging CGRP-targeted therapies and their novelty within the migraine medication market.

Emlah Tubuo, PharmD, MS, owner of Powell Pharmacy and founder of Emlah Consulting LLC, discusses her approaches to supplement marketing.

Amaal J. Starling, MD, FAAN, FAHS, and Courtney Hahs, PharmD, address the challenges in migraine care and how a lack of access and workforce are creating opportunities for pharmacists.